In an earnings call covering its 2024 full-year results, executives from Ekso Bionics (Nasdaq: EKSO) described the company’s plans to get its Ekso Indego Personal exoskeleton into the hands of more patients. “Revenue of $17.9 million was down from $18.3 million for the same period in 2023,” Ekso Bionics CFO Jerome Wong said, in describing…
Ekso Bionics to Focus on Indego Personal Exoskeleton Expansion Through CRT, DME Channels
NSM Signs Exclusive Partnership to Distribute Indego Exoskeleton in CRT Market
The Centers for Medicare & Medicaid Services has classified some exoskeletons as braces.
National Seating & Mobility (NSM) has become the exclusive distributor of the Ekso Indego Personal exoskeleton in the Complex Rehab Technology (CRT) industry. In a Feb. 10 news announcement, NSM said the new partnership with Ekso Bionics Holdings Inc. (Nasdaq: EKSO), headquartered in San Rafael, California, will “broaden access to the Ekso Indego-powered exoskeleton device…
Review: Webinar Compares Brain-Computer Interface Technologies, Predicts Timelines for Success
BCI technology could be used to control wheelchairs, exoskeletons and prosthetics.
Brain-computer interface (BCI) technology is already turning science-fiction concepts into everyday realities. But there are many different “mind control” approaches, with different goals and applications, and differing levels of invasiveness for the components that interact with the user’s brain. IDTechEx, an independent research firm focusing on emerging tech and related markets, took a deeper dive…
Commentary: Once Again, Wheelchairs Considered Second-Class Solutions
Medicare is now funding personal exoskeletons. But what’s so wrong about rolling?
In April, the Centers for Medicare & Medicaid Services (CMS) announced Medicare coverage for personal exoskeletons. ReWalk (DBA: Lifeward), an exoskeleton manufacturer, praised the decision: “The Centers for Medicare & Medicaid Services has officially revised its April 2024 Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fee schedule to include a final lump-sum Medicare purchase…
ReWalk Robotics Lauds Medicare Allowable for Personal Exoskeletons
The final payment rate affects claims with dates of service on or after April 1.
ReWalk Robotics Ltd. (DBA: Lifeward) is lauding the Centers for Medicare & Medicaid Services’ (CMS) decision to provide Medicare coverage for personal exoskeletons. In an April 12 announcement, ReWalk — which manufactures the ReWalk personal exoskeleton and the ReStore Exo-Suit, among other rehabilitation products — said, “The Centers for Medicare & Medicaid Services has officially…